IL191842A0
(en )
2008-12-29
Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers
HK1200092A1
(en )
2015-07-31
Sustained release formulations
IL184460A0
(en )
2007-10-31
Sustained release pharmaeutical formulations
IL209494A
(en )
2015-07-30
Insulin-oligomer monoconjugates, formulations and uses thereof
EP1879626A4
(en )
2011-03-23
Amphiphilic polymers and methods of use thereof
ZA200710270B
(en )
2008-12-31
Modified and immediate release memantine bead formulation
ZA200802602B
(en )
2009-10-28
Controlled release formulation
IL188964A0
(en )
2008-08-07
Sustained drug release composition
EP1721933A4
(en )
2010-01-20
Composition containing amphoteric water-soluble polymer
EP1799213A4
(en )
2010-10-06
Novel curcumin analogues and uses thereof
EP1802588A4
(en )
2010-02-17
Substituted amino-pyrimidones and uses thereof
EP1894976A4
(en )
2009-05-06
Polymer composition and polymer light-emitting device using same
EP1765385A4
(en )
2008-08-27
Sustained release vaccine composition
EP1719794A4
(en )
2010-04-28
Novel polymers and uses thereof
EP1714643A4
(en )
2011-03-02
Sustained release preparation
EP1841545A4
(en )
2012-04-04
Asphalt release agent
EP1802346A4
(en )
2011-07-06
Sustained release pharmaceutical composition
EP1753468A4
(en )
2010-05-26
Carboranylporphyrins and uses thereof
IL179296A0
(en )
2007-03-08
Amphiphilic polymer compositions and their use
EP1976546A4
(en )
2011-05-25
Cyclodextrin-containing polymers and uses thereof
EP1753405A4
(en )
2008-09-17
Controlled release pharmaceutical formulation
IL181300A0
(en )
2008-04-13
Photosensitizer formulations and uses thereof
PL2247282T3
(en )
2015-03-31
Sustained release formulation comprising octreotide and three linear polylactide-co-glycolide polymers
ZA200803627B
(en )
2009-10-28
Polymers incorporating 1,3 and 1,4 cyclohexnedimethanol
EP1741740A4
(en )
2009-07-01
Polymer having oxocarbon group and use thereof